Predictive value of early 18F-FDG PET/CT studies for treatment response evaluation to ipilimumab in metastatic melanoma: preliminary results of an ongoing study-Reference-Cited by-同舟云学术

Predictive value of early 18F-FDG PET/CT studies for treatment response evaluation to ipilimumab in metastatic melanoma: preliminary results of an ongoing study

Published:2014-10-31 Issue:3 Volume:42 Page:386-396
ISSN:1619-7070
Container-title:European Journal of Nuclear Medicine and Molecular Imaging
language:en
Short-container-title:Eur J Nucl Med Mol Imaging

Author:

Sachpekidis Christos,Larribere Lionel,Pan Leyun,Haberkorn Uwe,Dimitrakopoulou-Strauss Antonia,Hassel Jessica C.

Publisher

Springer Science and Business Media LLC

Subject

Radiology, Nuclear Medicine and imaging,General Medicine,Radiology, Nuclear Medicine and imaging,General Medicine

Link

http://link.springer.com/content/pdf/10.1007/s00259-014-2944-y.pdf

Reference43 articles.

1. Fellner C. Ipilimumab (Yervoy) prolongs survival in advanced melanoma: serious side effects and a hefty price tag may limit its use. P T. 2012;37:503–30.

2. World Health Organization. Skin cancers. Available at: http://www.who.int/uv/faq/skincancer/en/index1.html . Accessed 25 Oct 2014.

3. National Cancer Institute. SEER stat fact sheets: melanoma of the skin. Available at: http://seer.cancer.gov/statfacts/html/melan.html . Accessed 25 Oct 2014.

4. International Agency for Research on Cancer. World Health Organization. Malignant melanoma of skin. Available at: http://eu-cancer.iarc.fr/EUCAN/Cancer.aspx?Cancer=20 . Accessed 25 Oct 2014.

5. Hodi FS, O’Day SJ, McDermott DF, Weber RW, Sosman JA, Haanen JB, et al. Improved survival with ipilimumab in patients with metastatic melanoma. N Engl J Med. 2010;368:711–23.

Cited by 129 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Immune checkpoint inhibitors in pediatric patients with melanoma: a systematic literature review;Melanoma Management;2024-08-26

2. Symptomatic pseudoprogression in metastatic colorectal cancer;BMJ Case Reports;2024-06

3. Metabolic Profiling to Assess Response to Targeted and Immune Therapy in Melanoma;International Journal of Molecular Sciences;2024-01-31

4. FDG PET/CT Imaging 1 Week after a Single Dose of Pembrolizumab Predicts Treatment Response in Patients with Advanced Melanoma;Clinical Cancer Research;2024-01-24

5. Navigating the ICI Combination Treatment Journey: Patterns of Response and Progression to First-Line ICI-Based Combination Treatment in Metastatic Renal Cell Carcinoma;Journal of Clinical Medicine;2024-01-05